应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
RZLT Rezolute, Inc.
盘前交易 07-19 06:11:59 EDT
4.41
-0.23
-4.96%
最高
4.75
最低
4.28
成交量
29.70万
今开
4.71
昨收
4.64
日振幅
10.05%
总市值
2.34亿
流通市值
1.73亿
总股本
5,317万
成交额
132.20万
换手率
0.76%
流通股本
3,918万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Rezolute, Inc.盘中异动 股价大跌5.17%
自选股智能写手 · 07-18 22:50
Rezolute, Inc.盘中异动 股价大跌5.17%
Rezolute, Inc.盘中异动 股价大涨6.49%报5.09美元
自选股智能写手 · 07-17 21:31
Rezolute, Inc.盘中异动 股价大涨6.49%报5.09美元
Rezolute, Inc.盘中异动 早盘股价大涨6.31%报4.55美元
自选股智能写手 · 07-12
Rezolute, Inc.盘中异动 早盘股价大涨6.31%报4.55美元
Rezolute, Inc.盘中异动 急速上涨5.21%
自选股智能写手 · 07-11
Rezolute, Inc.盘中异动 急速上涨5.21%
BUZZ-Rezolute 因股票发行定价而暴跌
Reuters · 06-14
BUZZ-Rezolute 因股票发行定价而暴跌
BUZZ-Rezolute 推出股票后下滑
Reuters · 06-14
BUZZ-Rezolute 推出股票后下滑
Rezolute, Inc.盘中异动 早盘快速拉升5.69%
自选股智能写手 · 06-05
Rezolute, Inc.盘中异动 早盘快速拉升5.69%
Rezolute, Inc.盘中异动 股价大涨5.33%报4.35美元
自选股智能写手 · 05-30
Rezolute, Inc.盘中异动 股价大涨5.33%报4.35美元
Rezolute, Inc.盘中异动 快速上涨5.42%报3.89美元
自选股智能写手 · 05-29
Rezolute, Inc.盘中异动 快速上涨5.42%报3.89美元
Rezolute, Inc.盘中异动 早盘大幅拉升5.23%
自选股智能写手 · 05-24
Rezolute, Inc.盘中异动 早盘大幅拉升5.23%
Rezolute, Inc.盘中异动 股价大跌5.33%报2.66美元
自选股智能写手 · 05-23
Rezolute, Inc.盘中异动 股价大跌5.33%报2.66美元
Rezolute, Inc.盘中异动 早盘急速上涨21.67%报3.65美元
自选股智能写手 · 05-22
Rezolute, Inc.盘中异动 早盘急速上涨21.67%报3.65美元
BUZZ-Rezolute眼病药物达到中期研究的主要目标,药价飙升
Reuters · 05-22
BUZZ-Rezolute眼病药物达到中期研究的主要目标,药价飙升
HC Wainwright & Co.:重申Rezolute(RZLT.US)评级,由买入调整至买入评级, 目标价14.00美元。
智通财经 · 05-16
HC Wainwright & Co.:重申Rezolute(RZLT.US)评级,由买入调整至买入评级, 目标价14.00美元。
Rezolute Inc 报告截至 3 月的季度业绩 - 收益摘要
Reuters · 05-16
Rezolute Inc 报告截至 3 月的季度业绩 - 收益摘要
Rezolute, Inc.盘中异动 早盘大幅下跌5.69%
自选股智能写手 · 05-13
Rezolute, Inc.盘中异动 早盘大幅下跌5.69%
Rezolute, Inc.盘中异动 早盘股价大涨5.26%报3.00美元
自选股智能写手 · 05-10
Rezolute, Inc.盘中异动 早盘股价大涨5.26%报3.00美元
Rezolute, Inc.盘中异动 下午盘大幅跳水5.14%报2.77美元
自选股智能写手 · 05-10
Rezolute, Inc.盘中异动 下午盘大幅跳水5.14%报2.77美元
Rezolute, Inc.盘中异动 早盘快速下挫5.08%报3.10美元
自选股智能写手 · 05-07
Rezolute, Inc.盘中异动 早盘快速下挫5.08%报3.10美元
Rezolute Inc 预计每股亏损 30 美分 - 财报前瞻
Reuters · 05-07
Rezolute Inc 预计每股亏损 30 美分 - 财报前瞻
公司概况
公司名称:
Rezolute, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Rezolute, Inc.于2010年在特拉华州成立。该公司是一家临床阶段的生物制药公司,开发与慢性葡萄糖失衡相关的代谢疾病的疗法。该公司的主要临床资产RZ358是一种治疗先天性高胰岛素血症的潜在药物,这是一种极其罕见的儿科遗传性疾病,其特征是胰腺产生过多的胰岛素。
发行价格:
--
{"stockData":{"symbol":"RZLT","market":"US","secType":"STK","nameCN":"Rezolute, Inc.","latestPrice":4.41,"timestamp":1721332800000,"preClose":4.64,"halted":0,"volume":296959,"delay":0,"floatShares":39176200,"shares":53172569,"eps":-1.139879,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.23,"latestTime":"07-19 06:11:59 EDT","open":4.71,"high":4.7464,"low":4.28,"amount":1321969.41071,"amplitude":0.100517,"askPrice":4.9,"askSize":600,"bidPrice":4.04,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.139879,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721395800000},"adr":0,"adjPreClose":4.41,"postHourTrading":{"tag":"盘后","latestPrice":4.41,"preClose":4.41,"latestTime":"19:41 EDT","volume":132,"amount":583.8551,"timestamp":1721346090671},"volumeRatio":0.6928180542138253,"impliedVol":1.9104,"impliedVolPercentile":0.75},"requestUrl":"/m/hq/s/RZLT/wiki","defaultTab":"wiki","newsList":[{"id":"2452143338","title":"Rezolute, Inc.盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452143338","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452143338?lang=zh_cn&edition=full","pubTime":"2024-07-18 22:50","pubTimestamp":1721314227,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日22时50分,Rezolute, Inc.股票出现异动,股价大幅下跌5.17%。Rezolute, Inc.股票所在的生物技术行业中,整体跌幅为0.65%。Rezolute, Inc.公司简介:Rezolute Inc 是一家生物制药公司。消息层面,截至22时50分,《BTIG首予Rezolute买入评级,目标价13美元》资讯为影响Rezolute, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407182250279681e19e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407182250279681e19e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"2452515220","title":"Rezolute, Inc.盘中异动 股价大涨6.49%报5.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452515220","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452515220?lang=zh_cn&edition=full","pubTime":"2024-07-17 21:31","pubTimestamp":1721223099,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日21时31分,Rezolute, Inc.股票出现异动,股价快速拉升6.49%。截至发稿,该股报5.09美元/股,成交量2.5727万股,换手率0.05%,振幅1.46%。Rezolute, Inc.股票所在的生物技术行业中,整体跌幅为0.74%。其相关个股中,Aditxt, Inc.、Aptevo Therapeutics Inc.、Longeveron Inc.涨幅较大,Aditxt, Inc.、Aptevo Therapeutics Inc.、Longeveron Inc.较为活跃,换手率分别为644.88%、468.32%、95.88%,振幅较大的相关个股有Aditxt, Inc.、Seres Therapeutics, Inc.、Aptevo Therapeutics Inc.,振幅分别为13.13%、10.63%、6.96%。Rezolute, Inc.公司简介:Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717213139941f7e3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717213139941f7e3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RZLT"],"gpt_icon":0},{"id":"2450353988","title":"Rezolute, Inc.盘中异动 早盘股价大涨6.31%报4.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450353988","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450353988?lang=zh_cn&edition=full","pubTime":"2024-07-12 22:02","pubTimestamp":1720792947,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日22时02分,Rezolute, Inc.股票出现波动,股价快速拉升6.31%。截至发稿,该股报4.55美元/股,成交量4.5978万股,换手率0.09%,振幅5.37%。Rezolute, Inc.股票所在的生物技术行业中,整体涨幅为1.34%。其相关个股中,Qualigen Therapeutics, Inc.、Zura Bio Limited C/Wts 、Instil Bio, Inc.涨幅较大,Qualigen Therapeutics, Inc.、Clearmind Medicine Inc.、Kazia Therapeutics Limited较为活跃,换手率分别为1479.00%、87.41%、39.61%,振幅较大的相关个股有Qualigen Therapeutics, Inc.、Surrozen Inc C/Wts 01/08/2031 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ,振幅分别为80.37%、48.15%、32.83%。Rezolute, Inc.公司简介:Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712220227aef97bc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712220227aef97bc2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"2450005841","title":"Rezolute, Inc.盘中异动 急速上涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450005841","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450005841?lang=zh_cn&edition=full","pubTime":"2024-07-11 02:37","pubTimestamp":1720636661,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日02时37分,Rezolute, Inc.股票出现异动,股价急速上涨5.21%。截至发稿,该股报4.44美元/股,成交量30.2134万股,换手率0.57%,振幅6.87%。Rezolute, Inc.股票所在的生物技术行业中,整体涨幅为1.38%。其相关个股中,Kazia Therapeutics Limited、Virpax Pharmaceuticals, Inc.、Longeveron Inc.涨幅较大,Virpax Pharmaceuticals, Inc.、Soligenix, Inc.、Kazia Therapeutics Limited较为活跃,换手率分别为4114.89%、1545.49%、1346.38%,振幅较大的相关个股有Kazia Therapeutics Limited、Revolution Medicines Inc C/Wts 17/12/2026 、Virpax Pharmaceuticals, Inc.,振幅分别为421.88%、133.16%、130.17%。Rezolute, Inc.公司简介:Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711023742af91a2f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711023742af91a2f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"2443235266","title":"BUZZ-Rezolute 因股票发行定价而暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2443235266","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443235266?lang=zh_cn&edition=full","pubTime":"2024-06-14 19:08","pubTimestamp":1718363339,"startTime":"0","endTime":"0","summary":" 6月14日 - ** Rezolute Inc 股价下跌18.6%,报4.20美元。** 发行价较股票最后收盘价折价 22.5%** 公司已发行股票约 4010 万股,市值约 2.07 亿美元。伦敦证券交易所集团的数据显示,该公司有约 31.8 股的公众流通股。** 5 月 21 日,Rezolute 称其眼病药物 RZ402 在治疗糖尿病黄斑水肿患者的中期研究中达到了主要目标 。2023 年底股价为 99 美分** Jefferies 和 Cantor 是股票发行的联合账簿管理人","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RZLT","BUZZ","BK4139"],"gpt_icon":0},{"id":"2443265560","title":"BUZZ-Rezolute 推出股票后下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2443265560","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443265560?lang=zh_cn&edition=full","pubTime":"2024-06-14 04:34","pubTimestamp":1718310867,"startTime":"0","endTime":"0","summary":" 6月13日 - ** 生物制药公司Rezolute Inc 寻求股票融资,盘后股价下跌约16** 专注于罕见病的公司开始发行 股票和预融资认股权证;交易规模未披露** Jefferies 和 Cantor 是联合账簿管理人** LSEG 数据显示,该公司拥有约 4010 万股流通股,市值约 2.07 亿美元,公众持股量约为 31.8 股。** 上个月,该公司称眼病药物 RZ402 在治疗糖尿病黄斑水肿患者的中期研究中达到了主要目标 ** RZLT 周四收盘下跌 5.8%,报 5.16 美元。该股在过去一个月中上涨了约 93%,2023 年收盘价为 99 美分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","RZLT","BK4139"],"gpt_icon":0},{"id":"2441125277","title":"Rezolute, Inc.盘中异动 早盘快速拉升5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441125277","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441125277?lang=zh_cn&edition=full","pubTime":"2024-06-05 22:43","pubTimestamp":1717598604,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日22时43分,Rezolute, Inc.股票出现异动,股价急速上涨5.69%。截至发稿,该股报4.91美元/股,成交量21.5054万股,换手率0.54%,振幅6.24%。Rezolute, Inc.股票所在的生物技术行业中,整体涨幅为0.96%。其相关个股中,Kineta, Inc.、诺瓦瓦克斯医药、Vir Biotechnology, Inc.涨幅较大,Cns Pharmaceuticals, Inc.、Adial Pharmaceuticals, Inc、Mustang Bio, Inc.较为活跃,换手率分别为55.38%、48.12%、10.21%,振幅较大的相关个股有Kineta, Inc.、Biocardia Inc C/Wts 06/08/2024、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为63.28%、41.80%、30.30%。Rezolute, Inc.公司简介:Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060522432596812347&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060522432596812347&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"2439362808","title":"Rezolute, Inc.盘中异动 股价大涨5.33%报4.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439362808","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439362808?lang=zh_cn&edition=full","pubTime":"2024-05-30 22:18","pubTimestamp":1717078736,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日22时18分,Rezolute, Inc.股票出现波动,股价急速拉升5.33%。截至发稿,该股报4.35美元/股,成交量12.0105万股,换手率0.30%,振幅8.72%。Rezolute, Inc.股票所在的生物技术行业中,整体跌幅为0.09%。Rezolute, Inc.公司简介:Rezolute Inc 是一家生物制药公司。消息层面,截至22时18分,《RezoluteROBERTS BRIAN KENNETH增持7,500股普通股股份,价值约2.01万美元》资讯为影响Rezolute, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530221857af8b2a30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530221857af8b2a30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"2439573778","title":"Rezolute, Inc.盘中异动 快速上涨5.42%报3.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439573778","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439573778?lang=zh_cn&edition=full","pubTime":"2024-05-29 22:21","pubTimestamp":1716992472,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日22时21分,Rezolute, Inc.股票出现异动,股价急速上涨5.42%。截至发稿,该股报3.89美元/股,成交量16.0958万股,换手率0.40%,振幅8.67%。Rezolute, Inc.股票所在的生物技术行业中,整体跌幅为1.10%。Rezolute, Inc.公司简介:Rezolute Inc 是一家生物制药公司。消息层面,截至22时21分,《RezoluteROBERTS BRIAN KENNETH增持7,500股普通股股份,价值约2.01万美元》资讯为影响Rezolute, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529222112941eae87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529222112941eae87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RZLT"],"gpt_icon":0},{"id":"2437581280","title":"Rezolute, Inc.盘中异动 早盘大幅拉升5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437581280","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437581280?lang=zh_cn&edition=full","pubTime":"2024-05-24 21:59","pubTimestamp":1716559178,"startTime":"0","endTime":"0","summary":"北京时间2024年05月24日21时59分,Rezolute, Inc.股票出现异动,股价急速拉升5.23%。Rezolute, Inc.股票所在的生物技术行业中,整体涨幅为0.02%。Rezolute, Inc.公司简介:Rezolute Inc 是一家生物制药公司。消息层面,截至21时59分,《JMP Securities维持Rezolute买入评级,维持目标价7美元》资讯为影响Rezolute, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240524215938941ea055&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240524215938941ea055&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"2437757205","title":"Rezolute, Inc.盘中异动 股价大跌5.33%报2.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437757205","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437757205?lang=zh_cn&edition=full","pubTime":"2024-05-23 21:38","pubTimestamp":1716471488,"startTime":"0","endTime":"0","summary":"北京时间2024年05月23日21时38分,Rezolute, Inc.股票出现异动,股价快速下挫5.33%。截至发稿,该股报2.66美元/股,成交量16.1024万股,换手率0.40%,振幅3.56%。Rezolute, Inc.股票所在的生物技术行业中,整体涨幅为0.04%。Rezolute, Inc.公司简介:Rezolute Inc 是一家生物制药公司。消息层面,截至21时38分,《JMP Securities维持Rezolute买入评级,维持目标价7美元》资讯为影响Rezolute, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240523213809aef156c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240523213809aef156c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"2437293103","title":"Rezolute, Inc.盘中异动 早盘急速上涨21.67%报3.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437293103","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437293103?lang=zh_cn&edition=full","pubTime":"2024-05-22 21:30","pubTimestamp":1716384625,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日21时30分,Rezolute, Inc.股票出现异动,股价快速上涨21.67%。截至发稿,该股报3.65美元/股,成交量448.432万股,换手率11.17%,振幅1.33%。Rezolute, Inc.股票所在的生物技术行业中,整体涨幅为0.49%。其相关个股中,Immunome, Inc.、Barinthus Biotherapeutics Plc、Dermata Therapeutics, Inc.涨幅较大,Mustang Bio, Inc.、Biodexa Pharmaceuticals Plc、Coeptis Therapeutics Holdings, Inc.较为活跃,换手率分别为181.22%、80.96%、32.10%,振幅较大的相关个股有Indaptus Therapeutics, Inc.、Nanobiotix、Scholar Rock Holding Corporation,振幅分别为14.04%、4.92%、4.73%。Rezolute, Inc.公司简介:Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522213025af89adb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522213025af89adb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"2437799154","title":"BUZZ-Rezolute眼病药物达到中期研究的主要目标,药价飙升","url":"https://stock-news.laohu8.com/highlight/detail?id=2437799154","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437799154?lang=zh_cn&edition=full","pubTime":"2024-05-22 05:42","pubTimestamp":1716327737,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 5月21日 - ** 药物开发商Rezolute公司 的股票在延时交易中飙升60%至4.80美元** 该公司称其治疗一种眼病的实验性药物达到了一项中期研究的主要目标 ** RZLT正在未经治疗和接受过有限治疗的患者中测试这种名为RZ402的药物。 ** 公司称,该药物有助于减轻视网膜肿胀,而视网膜肿胀可导致视力模糊或视力丧失** 称该药物安全且耐受性良好,3 名参与者出现了严重不良事件,经查与研究疗法无关 ** 股价在年初增长了两倍多","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RZLT","BK4139","BUZZ"],"gpt_icon":0},{"id":"2435604551","title":"HC Wainwright & Co.:重申Rezolute(RZLT.US)评级,由买入调整至买入评级, 目标价14.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435604551","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435604551?lang=zh_cn&edition=full","pubTime":"2024-05-16 23:44","pubTimestamp":1715874295,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.:重申Rezolute(RZLT.US)评级,由买入调整至买入评级, 目标价14.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051623445987711218&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051623445987711218&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT"],"gpt_icon":0},{"id":"2435698544","title":"Rezolute Inc 报告截至 3 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2435698544","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435698544?lang=zh_cn&edition=full","pubTime":"2024-05-16 05:16","pubTimestamp":1715807812,"startTime":"0","endTime":"0","summary":" * Rezolute Inc 报告了截至3月底的季度调整后每股亏损34美分,低于去年同期的每股-30美分。七位分析师对该季度的平均预期是每股亏损 30 美分。华尔街预期为每股-36美分至-19美分。* Rezolute Inc 报告的季度每股收益为亏损 34 美分。* 该公司当季亏损 1,705 万美元。* Rezolute Inc 的股价本季度上涨了 5.1%,今年迄今为止上涨了 170.0%。5月15日 - 预测变化 * 在过去三个月里,分析师的平均盈利预期上升了约 4.9%。华尔街对 Rezolute 公司 12 个月目标价的中位数为 9.50 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RZLT"],"gpt_icon":0},{"id":"2435379504","title":"Rezolute, Inc.盘中异动 早盘大幅下跌5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435379504","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435379504?lang=zh_cn&edition=full","pubTime":"2024-05-13 22:22","pubTimestamp":1715610156,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日22时22分,Rezolute, Inc.股票出现异动,股价急速下挫5.69%。截至发稿,该股报2.82美元/股,成交量2.6074万股,换手率0.06%,振幅5.69%。Rezolute, Inc.股票所在的生物技术行业中,整体涨幅为1.32%。其相关个股中,Estrella Immunopharma Inc C/Wts 29/09/2028、Jasper Therapeutics Inc C/Wts 24/09/2026 、Ac Immune Sa涨幅较大,Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.、Cardio Diagnostics Holdings Inc.较为活跃,换手率分别为58.81%、33.96%、19.67%,振幅较大的相关个股有Tevogen Bio Holdings Inc.、Dbv Technologies、Portage Biotech Inc.,振幅分别为43.68%、36.84%、34.80%。Rezolute, Inc.公司简介:Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132222367a599c78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132222367a599c78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RZLT"],"gpt_icon":0},{"id":"2434585107","title":"Rezolute, Inc.盘中异动 早盘股价大涨5.26%报3.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434585107","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434585107?lang=zh_cn&edition=full","pubTime":"2024-05-10 21:30","pubTimestamp":1715347828,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日21时30分,Rezolute, Inc.股票出现波动,股价急速拉升5.26%。截至发稿,该股报3.00美元/股,成交量2962股,换手率0.01%,振幅0.00%。Rezolute, Inc.股票所在的生物技术行业中,整体涨幅为0.97%。其相关个股中,诺瓦瓦克斯医药、Artelo Biosciences Inc C/Wts 20/06/2024 、Iteos Therapeutics, Inc.涨幅较大,诺瓦瓦克斯医药、Allarity Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃,换手率分别为27.96%、16.40%、6.24%,振幅较大的相关个股有Cel-Sci Corporation、Azitra Inc、Lantern Pharma Inc.,振幅分别为9.27%、9.18%、5.58%。Rezolute, Inc.公司简介:Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510213028792706a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510213028792706a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"2434041959","title":"Rezolute, Inc.盘中异动 下午盘大幅跳水5.14%报2.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434041959","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434041959?lang=zh_cn&edition=full","pubTime":"2024-05-10 03:06","pubTimestamp":1715281599,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日03时06分,Rezolute, Inc.股票出现异动,股价大幅下挫5.14%。截至发稿,该股报2.77美元/股,成交量13.0229万股,换手率0.32%,振幅7.67%。Rezolute, Inc.股票所在的生物技术行业中,整体涨幅为1.05%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Seres Therapeutics, Inc.、Transcode Therapeutics, Inc.涨幅较大,Notable Labs, Ltd.、Allarity Therapeutics, Inc.、G1 Therapeutics, Inc.较为活跃,换手率分别为178.18%、176.23%、63.97%,振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Notable Labs, Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为58.46%、57.24%、51.69%。Rezolute, Inc.公司简介:Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405100306397926cde9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405100306397926cde9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RZLT"],"gpt_icon":0},{"id":"2433785806","title":"Rezolute, Inc.盘中异动 早盘快速下挫5.08%报3.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433785806","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433785806?lang=zh_cn&edition=full","pubTime":"2024-05-07 21:52","pubTimestamp":1715089927,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日21时52分,Rezolute, Inc.股票出现波动,股价大幅下跌5.08%。截至发稿,该股报3.10美元/股,成交量2.4031万股,换手率0.06%,振幅2.77%。Rezolute, Inc.股票所在的生物技术行业中,整体涨幅为0.49%。其相关个股中,Geovax Labs Inc C/Wts 29/09/2025、Clearmind Medicine Inc.、珐博进涨幅较大,Clearmind Medicine Inc.、Tc Biopharm Plc、Allarity Therapeutics, Inc.较为活跃,换手率分别为1242.76%、136.84%、56.73%,振幅较大的相关个股有Tc Biopharm Plc、Clearmind Medicine Inc.、Corvus Pharmaceuticals, Inc.,振幅分别为31.03%、29.06%、26.70%。Rezolute, Inc.公司简介:Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050721520787e861e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050721520787e861e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"gpt_icon":0},{"id":"2433520500","title":"Rezolute Inc 预计每股亏损 30 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433520500","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433520500?lang=zh_cn&edition=full","pubTime":"2024-05-07 20:27","pubTimestamp":1715084853,"startTime":"0","endTime":"0","summary":" * Rezolute Inc 预计在5月9日公布截至0001年1月1日的业绩时,季度收入将没有变化(预计)。* * LSEG分析师对Rezolute公司的平均预期是每股亏损30美分。* 目前,分析师对该公司股票的平均评级为 \"买入\",建议分类为 7 个 \"强烈买入 \"或 \"买入\",没有 \"持有\",也没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Rezolute Inc 的 12 个月目标价中位数为 9.50 美元,高于其上一次收盘价 3.27 美元。5月7日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RZLT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.rezolutebio.com","stockEarnings":[{"period":"1week","weight":0.0304},{"period":"1month","weight":0.1366},{"period":"3month","weight":0.2857},{"period":"6month","weight":3.4104},{"period":"1year","weight":1.194},{"period":"ytd","weight":3.4433}],"compareEarnings":[{"period":"1week","weight":-0.0069},{"period":"1month","weight":0.0076},{"period":"3month","weight":0.1161},{"period":"6month","weight":0.1456},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.1627}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Rezolute, Inc.于2010年在特拉华州成立。该公司是一家临床阶段的生物制药公司,开发与慢性葡萄糖失衡相关的代谢疾病的疗法。该公司的主要临床资产RZ358是一种治疗先天性高胰岛素血症的潜在药物,这是一种极其罕见的儿科遗传性疾病,其特征是胰腺产生过多的胰岛素。","yearOnYearQuotes":[{"month":1,"riseRate":0.833333,"avgChangeRate":0.418523},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.05511},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.056507},{"month":4,"riseRate":0.666667,"avgChangeRate":0.028295},{"month":5,"riseRate":0.428571,"avgChangeRate":0.047485},{"month":6,"riseRate":0.714286,"avgChangeRate":0.175136},{"month":7,"riseRate":0.428571,"avgChangeRate":0.333422},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.053596},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.09068},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.231648},{"month":11,"riseRate":0.166667,"avgChangeRate":0.042339},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.135705}],"exchange":"NASDAQ","name":"Rezolute, Inc.","nameEN":"Rezolute, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Rezolute, Inc.(RZLT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Rezolute, Inc.(RZLT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Rezolute, Inc.,RZLT,Rezolute, Inc.股票,Rezolute, Inc.股票老虎,Rezolute, Inc.股票老虎国际,Rezolute, Inc.行情,Rezolute, Inc.股票行情,Rezolute, Inc.股价,Rezolute, Inc.股市,Rezolute, Inc.股票价格,Rezolute, Inc.股票交易,Rezolute, Inc.股票购买,Rezolute, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Rezolute, Inc.(RZLT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Rezolute, Inc.(RZLT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}